DiaMedica Therapeutics Inc.

DMAC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$24-$19-$14-$14
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$2$2$2
Change in WC$2$0$1-$0
Other Non-Cash-$1-$1$0$0
Operating Cash Flow-$22-$19-$12-$12
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$50-$69-$46-$70
Inv. Sales/Matur.$59$51$57$49
Other Inv. Act.$0$0$0$0
Investing Cash Flow$9-$18$12-$21
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$12$37$0$30
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$12$37-$0$30
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$0$0-$3
Supplemental Information
Beg. Cash$5$5$5$7
End Cash$3$5$5$5
Free Cash Flow-$22-$19-$12-$12
DiaMedica Therapeutics Inc. (DMAC) Financial Statements & Key Stats | AlphaPilot